These observations in vitro, in mouse mammary tumor models, plus an initial in silico analysis of cells from TNBC patients, support an unrecognized regulatory role of PDIA3-expressing TAM in the tumor immune response. This evidence concerns the gene PDIA3 and breast cancer.